WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/143105    International Application No.:    PCT/US2011/035738
Publication Date: 17.11.2011 International Filing Date: 09.05.2011
C07D 215/54 (2006.01), C07D 401/12 (2006.01), C07D 409/14 (2006.01), C07D 413/12 (2006.01), A61K 31/4706 (2006.01), A61K 31/4709 (2006.01), A61P 11/00 (2006.01)
Applicants: GILEAD SCIENCES, INC. [US/US]; 333 Lakeside Drive Foster City, CA 94404 (US) (For All Designated States Except US).
BAKER, William, R. [US/US]; (US) (For US Only).
CAI, Shaopei [US/US]; (US) (For US Only).
KAPLAN, Joshua, Aaron [US/US]; (US) (For US Only).
KIM, Musong [US/US]; (US) (For US Only).
LOYER-DREW, Jennifer, Alissa [US/US]; (US) (For US Only).
PERREAULT, Stephane [CA/US]; (US) (For US Only).
PHILLIPS, Gary [US/US]; (US) (For US Only).
PURVIS, Lafe, J., II [US/US]; (US) (For US Only).
STASIAK, Marcin [US/US]; (US) (For US Only).
STEVENS, Kirk, L. [US/US]; (US) (For US Only).
VAN VELDHUIZEN, Josh [US/US]; (US) (For US Only)
Inventors: BAKER, William, R.; (US).
CAI, Shaopei; (US).
KAPLAN, Joshua, Aaron; (US).
KIM, Musong; (US).
LOYER-DREW, Jennifer, Alissa; (US).
PERREAULT, Stephane; (US).
PURVIS, Lafe, J., II; (US).
STASIAK, Marcin; (US).
STEVENS, Kirk, L.; (US).
Agent: ECK, Steven, R.; Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 (US)
Priority Data:
61/477,263 20.04.2011 US
61/333,020 10.05.2010 US
61/406,930 26.10.2010 US
Abstract: front page image
(EN)Provided are compounds of Formula (I): Wherein X is:(Formula (II)) or (Formula (III)) R1 and R2 together with the phenyl to which they are bound may form a bicyclic, fused heterocyclic ring, and all other variables are as defined herein, as well as their use in treating pulmonary inflammation or bronchoconstriction and compositions comprising and processes for preparing the same.
(FR)La présente invention concerne, des composés représentés par la formule (I), l'utilisation de ces composés pour le traitement de l'inflammation pulmonaire ou de la bronchoconstriction pulmonaire, des compositions comprenant ces composés, et des procédés permettant l'élaboration de ces composés. Dans la formule (I), X est un noyau représenté par les formules (II) ou (III), R1 et R2 forment ensemble, avec le phényle auquel ils sont liés, un noyau hétérocyclique bicyclique fusionné, et enfin, toutes les autres variables sont telles que définies dans la présente demande.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)